Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Prevalence of Thalassemia in Nigeria: Pathophysiology and Clinical Manifestations

View through CrossRef
There is evidence linking genes for thalassaemia, sickle cell diseases, and glucose-6-phosphate dehydrogenase (G6PD) deficiency to a high prevalence of malaria infection. Haemoglobinopathies are hereditary conditions that mostly results in thalassaemia and sickle-cell anaemia. The current global haemoglobin gene carrier population (i.e., healthy individuals who have acquired only one mutant gene from one parent) is between 1 and 5%. Some haemoglobinopathy genes (alpha-thal, beta-thal and HbS) cause alpha-thalassaemia, beta-thalassaemia and sickle-cell anaemia, respectively. Nigerians have a prevalence of 25–30% for sickle cell anaemia (SCA), G6PD, but both alpha thalassaemia and beta thalassaemia are at the lower limit. Thalassaemia and SCA have comparable clinical manifestations. which is quite prevalent in Nigeria? This could lead to underdiagnosis of thalassaemia, which accompany hypochromia and microcytosis, that could be mistaken for iron deficiency anaemia. Depending on the levels of foetal haemoglobin and haemoglobin A2, thalassemia, iron deficiency anaemia, and sickle cell disease continue to be the most common chronic types of anaemia. This review provides details information on the prevalence of thalassaemia in Nigeria and molecular mechanisms in the expression of thalassaemia genes. The authors also suggest various possible way to minimize the occurrences of thalassaemia in Nigeria
Title: Prevalence of Thalassemia in Nigeria: Pathophysiology and Clinical Manifestations
Description:
There is evidence linking genes for thalassaemia, sickle cell diseases, and glucose-6-phosphate dehydrogenase (G6PD) deficiency to a high prevalence of malaria infection.
Haemoglobinopathies are hereditary conditions that mostly results in thalassaemia and sickle-cell anaemia.
The current global haemoglobin gene carrier population (i.
e.
, healthy individuals who have acquired only one mutant gene from one parent) is between 1 and 5%.
Some haemoglobinopathy genes (alpha-thal, beta-thal and HbS) cause alpha-thalassaemia, beta-thalassaemia and sickle-cell anaemia, respectively.
Nigerians have a prevalence of 25–30% for sickle cell anaemia (SCA), G6PD, but both alpha thalassaemia and beta thalassaemia are at the lower limit.
Thalassaemia and SCA have comparable clinical manifestations.
which is quite prevalent in Nigeria? This could lead to underdiagnosis of thalassaemia, which accompany hypochromia and microcytosis, that could be mistaken for iron deficiency anaemia.
Depending on the levels of foetal haemoglobin and haemoglobin A2, thalassemia, iron deficiency anaemia, and sickle cell disease continue to be the most common chronic types of anaemia.
This review provides details information on the prevalence of thalassaemia in Nigeria and molecular mechanisms in the expression of thalassaemia genes.
The authors also suggest various possible way to minimize the occurrences of thalassaemia in Nigeria.

Related Results

Comprehensive analysis of a-and b-thalassemia genotypes and hematologic phenotypes
Comprehensive analysis of a-and b-thalassemia genotypes and hematologic phenotypes
Background: Guizhou Province is an area with high incidence of thalassemia. However, there are few large-sample studies on the correlation between genotypes and phenotypes in Guizh...
Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis
Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis
Objective: To retrospectively analyze thalassemia phenotypes and associated mortality among Yemeni patients seeking healthcare in Sana’a city, Yemen. Methods: This retrospect...
Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis
Thalassemia Phenotypes and Associated Mortality among Yemeni Patients: A Single-Center Retrospective Analysis
Objective: To retrospectively analyze thalassemia phenotypes and associated mortality among Yemeni patients seeking healthcare in Sana’a city, Yemen. Methods: This retrospect...
Demographics, clinical profiles and healthcare utilization of patients with beta thalassemia major: A single centered study
Demographics, clinical profiles and healthcare utilization of patients with beta thalassemia major: A single centered study
Thalassemia is an inherited autosomal recessive blood disorder that occurs due to abnormal form of hemoglobin in the blood. It is an autosomal recessive condition caused by decreas...
DIAGNOSTIC VALUE OF MENTZER INDEX FOR THALASSEMIA PREDICTION IN SUSPECTED PATIENTS OF PUNJAB
DIAGNOSTIC VALUE OF MENTZER INDEX FOR THALASSEMIA PREDICTION IN SUSPECTED PATIENTS OF PUNJAB
Thalassemia is a genetic disease and became a worldwide problem. Worldwide, about 3-8% of population are suffered from beta thalassemia. The aim of this study was to use Mentzer in...
Molecular characterization of beta globin gene in beta thalassemia patients at Hue Central Hospital
Molecular characterization of beta globin gene in beta thalassemia patients at Hue Central Hospital
Background: Thalassemia is the most common monogenic disease worldwide. The severity of thalassemia depends on the degree of imbalance between the α-globin and β-globin chains. The...
Epidemiological Characteristics and Family Relatives among Thalassemic Patients in Sulaimani City, Kurdistan Region, Iraq
Epidemiological Characteristics and Family Relatives among Thalassemic Patients in Sulaimani City, Kurdistan Region, Iraq
Thalassemia is a well-known inherited hematologic disorder caused by a decrease or an absence of globin production. Patients with thalassemia suffer from chronic hemolytic anemia a...
Mutation in thalassemia syndrome and clinical manifestation
Mutation in thalassemia syndrome and clinical manifestation
Introduction: Thalassemia intermedia is a term used to define a group of patients with β thalassemia in whom the clinical severity of the disease is somewhere between the mild sym...

Back to Top